Quantcast
  Free Report!
  5 Secrets to Short Term Stock Trading Success   
 


Win Over $12,000
Predicting the Direction of a Stock!


Stocks

Trading Ideas

Short Term
Long Term
All Trading Ideas


Trading Lessons

Strategies
Courses
Interviews
Glossary
All Trading Lessons


Daily Stock Setups

Connors Daily Battle Plan
Haggerty Professional
Kaltbaum Intra-day Set-ups
Short Term PowerRatings
Long Term PowerRatings
TM Indicators


Trading News

Markets Updates
Technical Alerts
Breaking News


PowerRatings

Short Term
Long Term
Charts


Indicators

Stocks
Market Bias


Quotes

Markets
Stocks
Charts
Level II
Historical Data
Options


Trading Contests

Up or Down


 
WallStreetAnalystReport.com: Stock Alert! NACEL Energy Corporation (OTC BB:NCEN)
Thursday, March 20, 2008; Posted: 05:24 AM
Mar 20, 2008 (M2 PRESSWIRE via COMTEX) -- USPR | news | PowerRating | PR Cha
Free Report!
The Only 3 Options Strategies You'll Ever Need
 
 
 

rts
-- Stocks to Watch: NACEL Energy Corporation (OTC BB:NCEN) , Cardiome Pharma Corp. (Nasdaq: CRME), Lev Pharmaceuticals, Inc. (OTCBB:LEVP) , Black Box Corp. (Nasdaq: BBOX), US Precious Metals Inc. (OTC BB: USPR

Featured Stock: NACEL Energy Corporation (OTC BB:NCEN) Current Price (1.69) www.WallStreetAnalystReport.com

NACEL ENERGY TO ADD 20 MW OF NEW CAPACITY IN NATION'S PREMIER WIND ENERGY CORRIDOR

CASPER, WY - Wednesday, March 19, 2008 - NACEL Energy Corporation (OTC BB "NCEN") (FRANKFURT: "4FC") ("NACEL Energy"), an emerging developer and aggregator of wind power infrastructure generating clean, renewable energy for America, today announced the Company will develop the 20-megawatt Blue Creek wind energy project located north of Amarillo, TX. West Texas is considered one of the premier wind energy development corridors in the United States. In addition to Nacel Energy, Shell, BP and Florida Power & Light also have wind energy development projects underway in the region.

NACEL Energy President Brian Lavery stated;

"The Blue Creek project enhances NACEL Energy's present operations and brings us closer to achieving the Company's primary goal of 80-megawatts of new power generation capacity under development over a 36 month period, thereby increasing enterprise and shareholder value."

In its latest update, The American Wind Energy Association (AWEA) reported that Texas consolidated its lead over California as the nation's number one wind power State, measured by installed capacity. In total, Texas wind farms now generate more than 4356-megawatts of power - enough energy to serve 1.5 million homes. (AWEA, "American Wind Energy Association Market Report," January 2008)

About NACEL Energy Corporation

NACEL Energy Corporation is a rapidly growing wind power generation company developing clean, renewable energy for America. NACEL Energy is among the first in the nation to develop COMMUNITY WIND - advantageous utility scale wind power generation projects with a sustainable footprint of 20 MW and the participation of local partners. With its expanding pipeline of new wind energy project assets, the Company is on track to develop 80 MW of energy to power 25,000 U.S. homes by 2010. NACEL Energy was founded in 2006 and is headquartered in Casper, Wyoming.

For more information visit our website www.nacelenergy.com

NACEL Energy The WIND POWER COMPANY TM

Notice regarding Forward-Looking Statements

Statements in this press release relating to Nacel Energy's plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking information is subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in Nacel Energy's business. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue," or similar terms or the negative of these terms. Matters discussed in today's news release, including, without limitation; the belief that the business assumptions underlying the statement "the Company will develop the 20-megawatt Blue Creek wind energy project" and such a project is "consistent with the Company's primary goal of achieving 80-megawatts of new power generation capacity over a 36 month period," are reasonable, and all other such similar statements of belief, are forward-looking statements that involve a number of risks and uncertainties. The actual future results of Nacel Energy could differ from these statements. Factors that could cause or contribute to such differences include, but are not limited to, the ability of Nacel Energy to acquire the capital necessary to fund its wind energy development plans; the ability of Nacel Energy's management to successfully execute partnership agreements with local wind energy developers; the ability of Nacel Energy to generate its projected internal rate of return from the wind energy projects it develops; and other additional factors discussed in "Risk Factors" and other sections of Nacel Energy's Securities and Exchange Commission filings available at www.sec.gov. Although Nacel Energy believes that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements and Nacel Energy accepts no obligation to update these forward-looking statements.

Contact:

Nacel Energy Investor Services 1-888-242-5848

For an in-depth analyst report, please visit: www.WallStreetAnalystReport.com

Cardiome Pharma Corp.

(Nasdaq: CRME | news | PowerRating | PR Charts ) Current Price (8.48) www.WallStreetAnalystReport.com VANCOUVER, March 17- Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) today announced positive interim clinical results from its 90-day Phase 2b study of vernakalant (oral). The interim analysis demonstrated statistically significant efficacy for the patient group receiving 500mg b.i.d. of vernakalant (oral) as compared to placebo. The safety data from the interim analysis also suggests that vernakalant (oral) was well-tolerated in the atrial fibrillation population studied during the dosing period under analysis. Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with two late-stage clinical drug programs focused on atrial arrhythmia (intravenous and oral dosing), a Phase 1 program for GED-aPC, an engineered analog of recombinant human activated Protein C, and a pre-clinical program directed at improving cardiovascular function.

Lev Pharmaceuticals, Inc.

(OTCBB:LEVP) Current Price (.80) www.WallStreetAnalystReport.com PHILADELPHIA & NEW YORK--Mar 18, 2008--Lev Pharmaceuticals, Inc. (OTCBB:LEVP.OB - News) today announced the presentation of results from a Phase III study examining the efficacy and safety of prophylactic use of its C1 inhibitor (C1INH) replacement therapy, Cinryze, in patients with hereditary angioedema (HAE). The findings, presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI), demonstrated that prophylactic use of Cinryze significantly decreases the number of attacks in HAE patients. Lev is a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Lev's C1 inhibitor, proposed to be marketed as Cinryze(TM), has been granted orphan drug status for the treatment and prevention of HAE, potentially securing, upon approval, market exclusivity for seven years. Lev has also received fast track designation status from the FDA, which facilitates the development and expedites the review of drugs and biologics intended to treat serious or life threatening conditions and that demonstrate the potential to address unmet medical needs. Lev is also evaluating the development of C1 inhibitor for the treatment of acute myocardial infarction, or heart attack, and selective other diseases and disorders in which inflammation is known or believed to play an underlying role.

Black Box Corp.

(Nasdaq: BBOX | news | PowerRating | PR Charts ) Current Price (28.60) www.WallStreetAnalystReport.com PITTSBURGH--Mar 17, 2008--Black Box Corporation (NASDAQ:BBOX - News) today announced that it has acquired AT&T Inc.'s (NYSE:ATT - News) NEC TDM voice CPE business line in AT&T's southeast region. Black Box is the world's largest technical services company dedicated to designing, building and maintaining today's complicated data and voice infrastructure systems. Black Box services 175,000 clients in 141 countries with 187 offices throughout the world.

US Precious Metals Inc.

(OTC BB: USPR Current Price (1.15) www.WallStreetAnalystReport.com CELEBRATION, Fla.--Mar 18, 2008--U.S. Precious Metals, Inc. (OTCBB: USPR - News) USPR Board members Sheldon Baer and Jerry Payne were accompanied by USPR investors, CEO Michael Floersch of Applied Minerals, Inc., President Dave Burney of USPR and Jose Garcia President of U.S. Precious Metals de Mexico along with other USPR staff members to the La Sabila Project site in southern Michoacan, Mexico on March 11th 2008. Director Baer said that the project tour focused on the progress of the drilling, evaluating the performance of the Niton XRF analyzer and the sampling of high grade zones of gold, silver and copper that were previously identified by USPR staff. The XRF analyzer proved very successful in identifying additional zones of gold, silver and copper mineralization. US Precious Metals, Inc. is a gold exploration company operating in Mexico through its wholly owned Mexican subsidiary, U.S. Precious Metals de Mexico. US Precious Metal's common stock is quoted on the OTC Bulletin Board under the symbol "USPR."

Penny Stocks traded in the Small Cap Markets who seek Investor Relations, can receive complete coverage from WallStreetAnalystReport.com. WallStreetAnalystReport.com covers Penny Stock analyst reports and strives to keep the Penny Stock Investor updated. It is essential that the smallcap stock investor stay informed when making decisions through Penny Stock analyst reports. Visitors can sign up for our penny stock newsletter and analyst reports, to be kept up to date when we begin coverage on new small cap companies. Coverage of micro cap stock Companies and Penny Stock analyst reports are provided by WallStreetAnalystReport.com. Sign up today and stay informed of your Investment, allow WallStreetAnalystReport.com to provide you with the latest analyst reports on small cap and pennystocks.

Wallstreetanalystreport.com is owned and operated by Iron Consulting LLC Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Growthstockanalyst.com is owned and operated by Iron Consulting. Iron Consulting www.ironconsultinginc.com has receive thirty six thousand dollars from Equity Alliance Intl. for one month of internet marketing services, from Equity Alliance Int. LLC www.equityallianceir.com for its marketing and consulting services. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

CONTACT: e-mail: ironconsulting@gmail.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

Morning Coffee with TradingMarkets -- Free Newsletter


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Stocks RSS Submit to del.icio.us Submit to Digg it



Most Popular


  As of ET
  Updates every 2 hrs

NameSymbolPR
Rait Financial Trust    RAS9
MasterCard Inc    MA9
American Oriental Bioengineeri...    AOB9
Western Refining Inc    WNR8
Savient Pharmaceuticals Inc    SVNT8
More Top Rated Stocks >>
Free Trial
Short Term   Long Term   PowerRatings Charts
PREMIER SPONSORED LINKS
TRADE CENTER
 
 
 

The TradingMarkets Directory
Stocks
Quotes
Charts
How to Trade
Commentary and Analysis
PowerRatings
Training Classes
Tools
Stock Scanner
Daily Market Bias

Options
Quotes
Charts
How to Trade
Commentary and Analysis

Forex
How to Trade
Forex Momentum Index
Pivots

E-mini/Futures
Quotes
Charts
How to Trade
Daily Market Bias

How to Trade
Stocks
Options
Forex
E-mini/Futures
Glossary

Tools
Short Term PowerRatings
Long Term PowerRatings
Stock Screener
Quotes & Charts
Stock Indicators
Market bias Indicators

PowerRatings
Short Term PowerRatings
Long Term PowerRatings
Industry PowerRatings
PowerRatings Charts
Training Classes
PowerRatings Strategies
Search PowerRatings

Trading Contests
Up or Down Stock Contest
#1 - Win $1000 every month

Up or Down Forex Contest -
Win $1000 every month


Premium Subscription Services
Short Term PowerRatings Free Trial
Long Term PowerRatings Free Trial
TradingMarkets Subscription Free Trial
Daily Battle Plan Free Trial
Gary Kaltbaum - Intraday Breaking Alerts Free Trial
Kevin Haggerty Professional Trading Service Free Trial
Forex Force with Mark Whistler Free Trial

RELATED SITES
Nothing but forex





All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.